ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C01BG11 | B | Vernakalant - 20mg/ml | 8368/945 | 117914/1 | BRINAVESS | 20mg/ml | 1 | Injectable concentrated solution | Infusion | Droguerie de l'Union | Hameln Pharmaceuticals GmbH | Germany | 41,821,582 L.L | 10.71 | E1 | Cardiome UK Limited | UK | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C01BG11 | B | Vernakalant - 20mg/ml | 8368 | 117914/1 | BRINAVESS | 20mg/ml | 1 | Injectable concentrated solution | Infusion | Droguerie de l'Union | Hameln Pharmaceuticals GmbH | Germany | 685,976 L.L | 10.71 | E1 | Cardiome UK Limited | UK | 2/5/2024 | |
C01BG11 | B | Vernakalant - 20mg/ml | 10826 | 71420/1 | BRINAVESS | 20mg/ml | 1 | Injectable concentrate for solution | Infusion | Droguerie de l'Union | Siegfried Hameln GmbH | Germany | 685,976 L.L | 10.71 | E1 | Correvio | France | 2/5/2024 | |
C01BG11 | B | Vernakalant - 20mg/ml | 10826/945 | 71420/1 | BRINAVESS | 20mg/ml | 1 | Injectable concentrate for solution | Infusion | Droguerie de l'Union | Siegfried Hameln GmbH | Germany | 41,821,582 L.L | 10.71 | E1 | Correvio | France | 2/5/2024 | 0 |